TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $15,000 | -68.8% | 23,351 | 0.0% | 0.01% | -58.3% |
Q3 2018 | $48,000 | -23.8% | 23,351 | 0.0% | 0.01% | -33.3% |
Q2 2018 | $63,000 | -38.2% | 23,351 | -49.1% | 0.02% | +63.6% |
Q1 2018 | $102,000 | -74.3% | 45,869 | -63.3% | 0.01% | -50.0% |
Q4 2017 | $397,000 | -56.7% | 124,966 | -59.5% | 0.02% | -35.3% |
Q3 2017 | $916,000 | +12.4% | 308,227 | -9.2% | 0.03% | +54.5% |
Q2 2017 | $815,000 | -36.0% | 339,539 | 0.0% | 0.02% | -45.0% |
Q1 2017 | $1,273,000 | -25.6% | 339,539 | -11.0% | 0.04% | -23.1% |
Q4 2016 | $1,711,000 | -15.0% | 381,477 | +14.1% | 0.05% | -31.6% |
Q3 2016 | $2,014,000 | +42.7% | 334,206 | -8.0% | 0.08% | -21.6% |
Q2 2016 | $1,411,000 | -38.8% | 363,292 | 0.0% | 0.10% | -31.2% |
Q1 2016 | $2,306,000 | -31.3% | 363,292 | 0.0% | 0.14% | -25.0% |
Q4 2015 | $3,357,000 | -5.4% | 363,292 | 0.0% | 0.19% | +54.1% |
Q3 2015 | $3,549,000 | -13.5% | 363,292 | -1.4% | 0.12% | +96.8% |
Q2 2015 | $4,104,000 | -17.9% | 368,330 | 0.0% | 0.06% | -77.7% |
Q1 2015 | $5,001,000 | – | 368,330 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
683 Capital Management, LLC | 995,000 | $3,134,000 | 0.33% |
NEA Management Company, LLC | 2,759,217 | $8,692,000 | 0.30% |
Eventide Asset Management | 900,000 | $2,835,000 | 0.16% |
QVT Financial LP | 308,227 | $916,000 | 0.03% |
Candriam S.C.A. | 143,000 | $450,000 | 0.01% |
Virtu Financial LLC | 23,684 | $75,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 13,352 | $42,000 | 0.00% |
BLUESTEIN R H & CO LLC | 16,000 | $50,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,135 | $171,000 | 0.00% |
Alyeska Investment Group, L.P. | 97,676 | $308,000 | 0.00% |